Infant, Newborn, Diseases Clinical Trial
Official title:
Early-Onset Sepsis an NICHD/CDC Surveillance Study
This prospective surveillance study will be conducted over a 2 year period to determine current rates of Early-Onset Sepsis (EOS)/ Early-Onset Meningitis (EOM), associated pathogens, antimicrobial resistance, signs and symptoms and infant outcomes.
Neonatal pathogens other than group B Streptococcus (GBS) and resistant to beta-lactam
antibiotics have emerged as the most common etiologic agents of EOS and EOM among preterm and
term neonates and result in high mortality rates, potentially offsetting the decreased burden
of early-onset GBS disease prevented by maternal intrapartum chemoprophylaxis.
Primary Outcomes of this study:
1. To determine current hospital-based rates of early-onset neonatal infection (total,
GA-specific and BW-specific, and pathogen-specific) in term and preterm infants in the
era of maternal intrapartum antibiotic prophylaxis to prevent vertical transmission of
group B streptococcal disease. Early-onset infection comprises EOS and/or EOM and is
defined as isolation of a pathogen from blood or cerebrospinal fluid (CSF) obtained
within 72 hours of birth and provision of appropriate antibiotic treatment for 5 or more
days (or <5 days if death occurs while receiving antibiotic therapy).
2. To determine the antimicrobial susceptibility patterns of organisms associated with EOS
and EOM
The case control aspect of this study will address 2 major conundrums regarding EOS: Can we
identify risk factors for early-onset Gram-negative infections that might lead to
intervention strategies to reduce risk and can we identify infants born to mothers with
clinical chorioamnionitis who are at highest risk for early-onset sepsis and thus warrant
antibiotic treatment soon after birth?
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05954975 -
Baby Sickness Evaluation
|
||
Not yet recruiting |
NCT05936112 -
Quantification of Fecal Calprotectin Concentration Difference Between Infants Aged Under 4 Months Old Suffering From Functional Gastrointestinal Disorders (FGID) and Infants Aged Under 4 Months Old Free From Disorders : a Transversal Case-control Monocentric Study
|
N/A | |
Completed |
NCT02968628 -
Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
|
||
Not yet recruiting |
NCT00994149 -
Diazoxide In the Management Of Hypoglycemic Neonates
|
Phase 2/Phase 3 | |
Completed |
NCT03571932 -
Assessment of Family Planning and Immunization Service Integration in Liberia
|
||
Completed |
NCT02865772 -
Lamellar Body Counts on Gastric Aspirate in Healthy Term Newborns
|
N/A | |
Completed |
NCT03535311 -
Estimating Insertion Length of Umbilical Catheters in Newborn Infants
|
||
Completed |
NCT00477594 -
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
|
Phase 2 | |
Recruiting |
NCT06139809 -
Noninvasive Positive Pressure Ventilation During Neonatal Nasal Intubation
|
N/A | |
Recruiting |
NCT03162653 -
Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome
|
Phase 3 | |
Not yet recruiting |
NCT06267508 -
Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
|
||
Completed |
NCT02701920 -
HeartLight: Heart Rate Monitoring for Newborn Resuscitation
|
||
Completed |
NCT01124331 -
Appropriate Oxygen Levels for Extremely Preterm Infants: a Prospective Meta-analysis
|
N/A | |
Active, not recruiting |
NCT04354220 -
Capnography Monitoring in Ventilated Children
|
||
Recruiting |
NCT05793723 -
Long-term Respiratory Complications in Infants With Perinatal COVID-19
|
||
Completed |
NCT03404284 -
Assessment of Family Planning and Immunization Service Integration in Malawi
|
N/A | |
Completed |
NCT01954056 -
Hydrocortisone for Term Hypotension
|
Phase 3 | |
Not yet recruiting |
NCT06255886 -
Treatment of Gastroesophageal Reflux Disease in Infants
|
Phase 4 | |
Completed |
NCT02434380 -
Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes
|
Phase 3 | |
Completed |
NCT00607373 -
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
|
Phase 3 |